Mandana T Manzari Honu

2PUBLICATIONS
17CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Dec 05, 2025
Tumor microenvironment-targeted PROTAC nanoparticle self-assembly broadly predicted by structural descriptors.

Kristen C Vogt, Magdalini Panagiotakopoulou, Mandana T Manzari Honu

|Sep 14, 2019
Genomically informed small-molecule drugs overcome resistance to a sustained-release formulation of an engineered death receptor agonist in patient-derived tumor models.

Mandana T Manzari, Gray R Anderson, Kevin H Lin

Pageof 1

Frequent Collaborators

1 joint publications

Gray R Anderson

1 joint publications

Chandler E Moore

1 joint publications

Rachel N Skelton

1 joint publications

Maréva Fèvre

1 joint publications

Suzanne E Wardell

1 joint publications

Kris C Wood

1 joint publications

Ashutosh Chilkoti

1 joint publications

Kristen C Vogt

1 joint publications

Magdalini Panagiotakopoulou

1 joint publications

Ana Marie Perea

Frequent Collaborators

1 joint publications

Gray R Anderson

1 joint publications

Chandler E Moore

1 joint publications

Rachel N Skelton

1 joint publications

Maréva Fèvre

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors
11:52

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Published on : Jun 18, 2013

11.4K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

5.7K
See more related videos

Top Related Videos

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors
11:52

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Published on : Jun 18, 2013

11.4K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

5.7K
See more related videos